Safety Analysis of Patients With Neuroendocrine Tumors (NETs) Receiving Concomitant Treatment With Telotristat Ethyl (TE) and Everolimus (EVE) in Phase 3 TELEPATH StudyRaul Perez-Olle,Polina Binder,Shanna Stanley,Eshetu Tesfaye,Praveen Tyle,Pablo LapuertaPANCREAS(2019)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要